Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Statins and cerebrovascular events].

Johann Auer1, Robert Berent, Bernd Eber

  • 1II. Interne Abteilung mit Kardiologie und internistische Intensivemedizin, Allegmeines Offentliches Krankenhaus der Barmherzigen, Schwestern vom Heiligen Kreuz Wels, Austria. johann.auer@khwels.at

Herz
|February 8, 2003
PubMed
Summary

Statins show promise in reducing ischemic stroke risk, comparable to aspirin. However, proven clinical benefit for stroke prevention in patients without coronary artery disease requires further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The choice of mitral valve surgery type and mid-term outcomes in patients up to 70 years of age: Results of the AUTHEARTVISIT study.

JTCVS open·2026
Same author

The prospective Austrian hypertrophic cardiomyopathy registry - design, methods and results of the run-in period.

Heart failure reviews·2026
Same author

Permanent Pacemaker Implantation After TAVI and Its Association with Survival: Single-Center Cohort and Nationwide Validation.

Journal of clinical medicine·2026
Same author

Determinants of Maximal Oxygen Consumption in Cardiac Rehabilitation Patients: The Role of Sex.

Journal of clinical medicine·2026
Same author

Short- and long-term outcomes following COVID-19 or Influenza hospitalization in adults: results of the AUTCOV study.

Frontiers in public health·2026
Same author

Correction to: Diagnosis and treatment of iron deficiency in chronic heart failure.

Wiener klinische Wochenschrift·2025

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Statins are widely used for cardiovascular risk reduction.
  • Previous studies and meta-analyses suggest statins reduce ischemic stroke incidence by approximately 30%.
  • Evidence is strongest in patients with established coronary heart disease (CHD).

Purpose:

  • To evaluate the efficacy of statins in stroke prevention, particularly in individuals without pre-existing coronary artery disease.
  • To assess the clinical benefit and safety of statin therapy for primary stroke prevention.

Summary:

  • Statins demonstrate a consistent ability to lower the incidence of ischemic stroke.
  • A meta-analysis estimated a 30% stroke risk reduction with statins, similar to aspirin.
  • The West of Scotland Primary Prevention (WOSCOPS) trial observed an 11% non-significant stroke reduction in patients without known coronary artery disease.

Related Experiment Videos

  • Strongest evidence for statin benefit, including stroke reduction, exists in patients with CHD.

    • Impact:

    • Clinical benefit of statins for stroke prevention in patients without coronary artery disease remains unproven.
    • Further research is needed to elucidate the influence of various drug properties and non-lipid mechanisms on clinical efficacy.
    • Future trials are essential to clarify statin's role in primary stroke prevention, especially in low-risk populations.